FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients 12 years and older.
A new study reveals long wait times, clinician shortages, and geographic gaps continue to delay diagnosis and treatment for patients with vulvar lichen sclerosus.
A recent study presented at ACOG 2025 highlights the potential of once-weekly secnidazole oral granules as an effective long-term therapy for recurrent bacterial vaginosis.
A new study highlights how dismissive medical experiences, including gaslighting, contribute to emotional distress and care avoidance among patients with vulvovaginal disorders.